The ASXL1 Gene Alterations in Patients with Myeloid Diseases and Chromosomal 20q Deletion

被引:0
|
作者
Brezinova, Jana [1 ]
Sarova, Iveta [1 ,2 ,3 ]
Lhotska, Halka [2 ,3 ]
Ransdorfova, Sarka [1 ]
Izakova, Silvia [2 ,3 ]
Svobodova, Karla [2 ,3 ]
Markova, Jana [1 ]
Zemanova, Zuzana [2 ,3 ]
Cermak, Jaroslav [1 ]
Jonasova, Anna T. [2 ]
Michalova, Kyra [1 ,2 ,3 ]
机构
[1] Inst Hematol & Blood Transfus, CR-12820 Prague, Czech Republic
[2] Gen Univ Hosp, Prague, Czech Republic
[3] Charles Univ Prague, Fac Med 1, Prague, Czech Republic
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [11] Myelodysplastic Syndromes (MDS) with 20q Deletion frequently show mutations in U2AF1, SRSF2 and ASXL1
    Bacher, U.
    Haferlach, T.
    Schnittger, S.
    Zenger, M.
    Grossmann, V
    Roller, A.
    Meggendorfer, M.
    Jeromin, S.
    Krauth, M-T
    Alpermann, T.
    Kern, W.
    Haferlach, C.
    ONKOLOGIE, 2013, 36 : 125 - 125
  • [12] C-SRC IS CONSISTENTLY CONSERVED IN THE CHROMOSOMAL DELETION (20Q) OBSERVED IN MYELOID DISORDERS
    LEBEAU, MM
    WESTBROOK, CA
    DIAZ, MO
    ROWLEY, JD
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (19) : 6692 - 6696
  • [13] Incidence of the ASXL1 gene in myeloid panel testing of AML and MDS patients
    Karakoyun, Hilal
    Yirmibes, Seren
    Milas, Ceyda
    Yararbas, Kanay
    Sahin, Deniz Goren
    Sayar, Ceyhan
    Yucel, Yazgi
    Arat, Mutlu
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 250 - 250
  • [14] Spectrum of Gene Mutations and Clinical Significance in Myeloid Malignancies Patients with ASXL1 Mutations
    Bai, Jie
    Teng, Guangshuai
    Wang, Yingshao
    Xu, Jing
    Du, Chenxiao
    Wang, Yan
    Chen, Yafang
    Sheng, Mengyao
    Bai, Jiaojiao
    Zhang, Lei
    Zhou, Yuan
    Yang, Feng-Chun
    BLOOD, 2018, 132
  • [15] Non-random chromosomal deletion clustering at 20q in Waldenstrom macroglobulinemia
    Kitahara, Toshihiko
    Umezu, Tomohiro
    Ando, Keiko
    Kodama, Atsushi
    Ohyashiki, Junko H.
    Ohyashiki, Kazuma
    HEMATOLOGY, 2011, 16 (03) : 139 - 142
  • [16] Delineation of a new chromosome 20q11.2 duplication syndrome including the ASXL1 gene
    Avila, Magali
    Kirchhoff, Maria
    Marle, Nathalie
    Hove, Hanna D.
    Chouchane, Mondher
    Thauvin-Robinet, Christel
    Masurel, Alice
    Mosca-Boidron, Anne-Laure
    Callier, Patrick
    Mugneret, Francine
    Kjaergaard, Susanne
    Faivre, Laurence
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2013, 161A (07) : 1594 - 1598
  • [17] Identification and Analysis of Oncogenic Pathways in Deletion 20q Acute Myeloid Leukaemia
    Ku, Matthew
    Narayan, Nisha
    MacKinnon, Ruth N.
    Wall, Meaghan
    Walkley, Carl
    Purton, Louise E.
    Cheng, Heung-Chin
    Campbell, Lynda J.
    Nandurkar, Harshal
    BLOOD, 2014, 124 (21)
  • [18] Identification and Analysis of Oncogenic Pathways in Deletion 20q Acute Myeloid Leukaemia
    Ku, Matthew
    Narayan, Nisha
    Wall, Meaghan
    MacKinnon, Ruth N.
    Campbell, Lynda J.
    Nandurkar, Harshal
    BLOOD, 2012, 120 (21)
  • [19] Analysis of ASXL1 Mutated T Cells in Patients with Myeloid Malignancies
    Fernandez, Eduardo
    Sanchez, Jesse
    Liang, Gangning
    Pospiech, Mateusz
    Li, Hongtao
    Manojlovic, Zarko
    Alachkar, Houda
    O'Connell, Casey L.
    BLOOD, 2023, 142
  • [20] Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
    Véronique Gelsi-Boyer
    Mandy Brecqueville
    Raynier Devillier
    Anne Murati
    Marie-Joelle Mozziconacci
    Daniel Birnbaum
    Journal of Hematology & Oncology, 5